Breaking News
January 20, 2018 - MSU scientists seek to identify brain mechanisms related to psychosis
January 20, 2018 - Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer
January 20, 2018 - Endoscopes Over Microscopes in Retinal Surgery: Ophthalmology Times
January 20, 2018 - Technology not taking over children’s lives despite screen-time increase
January 20, 2018 - Study finds extensive contamination around lead battery recycling plants in 7 African countries
January 20, 2018 - Flu may pass to others through exhaled breath, study shows
January 20, 2018 - Neuronal loss very limited in Alzheimer’s disease, new study shows
January 20, 2018 - Novel robot can aid treatment of rare birth defect
January 19, 2018 - TherapeuticsMD Announces Submission of New Drug Application for TX-001HR
January 19, 2018 - Fighting Infant Mortality | Medpage Today
January 19, 2018 - Researchers offer new evidence on four-year-old children’s knowledge about ecology
January 19, 2018 - Analysis finds overlooked crucial factor in determining prognosis for DIPGs
January 19, 2018 - Review explores consequences of genetic testing and cancer risk-reducing surgery
January 19, 2018 - Morning Break: HHS Div. of Religious Freedom; Trump’s Heart Health; Minister of Loneliness
January 19, 2018 - Parkinson’s disease ‘jerking’ side effect detected by algorithm
January 19, 2018 - New analysis finds dramatic increases in maternal mortality rates
January 19, 2018 - Weight-Loss Surgery’s Benefits Wane Over Time for Diabetics
January 19, 2018 - Cath Lab Recap: Sapien 3 Delivery System Recall; Transatlantic PCI Smackdown
January 19, 2018 - Parkinson’s treatment could be more effective, student finds
January 19, 2018 - New vaccine approach offers effective protection against tuberculosis
January 19, 2018 - Home care agencies often wrongly deny Medicare help to the chronically ill
January 19, 2018 - One hundred percent fruit juice does not alter blood sugar levels
January 19, 2018 - Prebiotics could enhance learning and memory skills in infants
January 19, 2018 - CMS May Cover MRI With Cardiac Devices Across the Board
January 19, 2018 - As income rises, women get slimmer—but not men
January 19, 2018 - Researchers develop adhesive materials to prevent bracket stains on teeth
January 19, 2018 - Flu can be spread without coughs and sneezes
January 19, 2018 - AMSBIO’s new recombinant protein shows great promise for organoid culture
January 19, 2018 - AbbVie’s Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis
January 19, 2018 - ASH: Pomalidomide Dose Escalation Improves Response
January 19, 2018 - Is your child’s school an obesity risk?
January 19, 2018 - Scientists describe groundbreaking training effect on the innate immune system
January 19, 2018 - MAST announces new AmpC, ESBL & Carbapenemase Detection Set
January 19, 2018 - Signaling molecules likely involved in concussions, rodent studies show
January 19, 2018 - Mast introduces Carba plus for CPE and OXA-48 confirmation
January 19, 2018 - Paleolithic diet helps overweight women maintain weight loss
January 19, 2018 - Agios Submits New Drug Application to the FDA for Ivosidenib for the Treatment of Patients with Relapsed/Refractory AML and an IDH1 Mutation
January 19, 2018 - This Flu Season, Don’t Forget About Tamiflu
January 19, 2018 - Amsterdam wins battle to host EU medicines agency after Brexit
January 19, 2018 - Study suggests movement as accurate method to diagnose neurodevelopmental disorders
January 19, 2018 - Maximize resolution in deep imaging for neuroscience research with Olympus TruResolution objectives
January 19, 2018 - Bilingualism may benefit children with ASD
January 19, 2018 - FDA Alert: Levofloxacin in 5 Percent Dextrose 250mg/50mL by AuroMedics: Recall
January 19, 2018 - USPSTF Not Backing Ankle-Brachial Index, CRP, or Coronary Calcium
January 19, 2018 - Higher omega-3 fatty acid intake tied to lower glaucoma risk
January 19, 2018 - Findings reveal conventional cancer therapy as double-edged sword
January 19, 2018 - Health Highlights: Jan. 16, 2018
January 19, 2018 - Morning Break: Anti-Emetic Warning; Uninsured Rate Jumps; Flu Worsens Saline Shortage
January 19, 2018 - Increased use of ambulatory surgery centers for cataract surgery
January 19, 2018 - Not-for-profit hospitals coming up with their own generic medicines to combat shortages
January 19, 2018 - $500 cancer detection blood tests may soon become reality
January 19, 2018 - Chronic traumatic encephalopathy may start early even without signs of concussions
January 19, 2018 - Warm-up program for children cuts soccer injuries by 50%
January 19, 2018 - ‘You’re Old and You Need Tests’: What We Heard This Week
January 19, 2018 - Egg-preserving hysterectomy raises heart risks later: study
January 19, 2018 - GA-map Dysbiosis Test identifies IBS patients who respond to FODMAP diet, study shows
January 19, 2018 - Study explores mortality and health-related habits in former elite athletes and their brothers
January 19, 2018 - New biodegradable sensors could assist doctors
January 19, 2018 - Modular gene enhancers may be suitable target in treatment of blood cancer
January 18, 2018 - New precision medicine trial for metastatic pancreatic cancer
January 18, 2018 - Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients
January 18, 2018 - Pre-Existing Patient-Valve Mismatch Trips Up ViV Implant
January 18, 2018 - Adolescents: health risks and solutions
January 18, 2018 - US woman delivers baby from embryo frozen for 24 years
January 18, 2018 - Study identifies new target for treatment of depression
January 18, 2018 - LJI study reveals key player that promotes skin inflammation in atopic dermatitis
January 18, 2018 - Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations
January 18, 2018 - Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla (AG200-15) for the Prevention of Pregnancy
January 18, 2018 - Gene Therapy for Inherited Retinal Dystrophy Gets FDA Clearance
January 18, 2018 - Researchers identify a new chemical pathway that helps the brain detect sweet, savory and bitter flavors
January 18, 2018 - IBV develops platform that helps companies to diagnose wellbeing of their workforce
January 18, 2018 - Study to test new precision medicine approach for metastatic pancreatic cancer
January 18, 2018 - World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows
January 18, 2018 - FDA Approves New Indication for Gilotrif (afatinib) in EGFR Mutation-Positive NSCLC
January 18, 2018 - Oncologists Dish on Top Issues for 2018
January 18, 2018 - Researchers identify new potential drug target for Huntington’s disease
January 18, 2018 - Metrohm USA welcomes employees to new headquarters in Florida
January 18, 2018 - Human waste remains main source of fecal pollution in the river Danube
January 18, 2018 - Expert discusses how to stay healthy during flu season
January 18, 2018 - New biomaterials-based system improves T-cell production
Bone marrow transplant stem cells can ‘swim’ upstream

Bone marrow transplant stem cells can ‘swim’ upstream

image_pdfDownload PDFimage_print
Credit: University of Pennsylvania

When a cancer patient receives a bone marrow transplant, time is of the essence. Healthy stem cells, which can restart the production of blood cells and immune system components after a patient’s own are compromised, need to make their way from the circulatory system into the bones as quickly as possible. To do that, they must find the spots where blood vessels and bone are in close contact.

Researchers at the University of Pennsylvania’s School of Engineering and Applied Science have found a property of these stem cells that may speed this restart. Like salmon returning to spawn, some stem cells fight the circulatory system’s rushing flow of blood and travel upstream.

Through in vitro experiments, the researchers have also begun to show which surface molecules are involved in these cells’ ability to anchor themselves to blood vessel walls and move themselves against the direction of flow. Understanding this process could lead to new ways of preparing the stem cells in a bone marrow transplant, making them faster and more effective.

The study was led by Alexander Buffone, a postdoctoral researcher in Chemical and Biomolecular Engineering, and Daniel Hammer, Alfred G. and Meta A. Ennis Professor in Bioengineering and in Chemical and Biomolecular Engineering. Graduate student and fellow Hammer lab member Nicholas Anderson also contributed to the study. It was published in the Journal of Cell Science.

The cells at the focus of this study, hematopoietic stem and progenitor cells, or HSPCs, include true stem cells as well as cells that have begun to differentiate but can still turn into a number of different blood and immune system components, such as red blood cells, platelets, neutrophils, T-cells and B-cells. Bone marrow transplants currently contain a mix of these HSPCs.

Hammer’s group studies the way immune cells attach to and move along the vascular surface. Experiments from Hammer’s lab and other groups had previously shown that T-cells can crawl against the flow, responding to chemical signals of inflammation that guide them to the culprit. Research has hypothesized that by backtracking along blood vessel walls, these T-cells can reach the source of the inflammatory signal without making a full lap of the circulatory system.

The researchers hypothesized that HSPCs might behave the same way. Using a mix of HSPCs similar to one that would be employed in a bone marrow transplant, they observed that a majority of cells naturally traveled upstream. They then set off to determine which, if any, types of HSPCs are more likely to exhibit this behavior, and what molecular factors push them one way or the other.

Hematopoietic stem and progenitor cells oriented with and against the direction of blood flow. The researchers showed that a particular receptor on the surface of HSPCs, known as LFA-1, is critical for traveling upstream; blocking it caused 95 percent of the cells tested to move along with the direction of flow. Credit: University of Pennsylvania

“As engineers, we’re looking at this complicated phenomenon on a small scale as opposed to a global scale. This way we may find something that immunologists or clinicians might miss,” Buffone said. “We engineer out the variables, with the ultimate goal of making mutant cell lines and seeing which ones make bone marrow transplants more successful.”

The group’s experiments consisted of monitoring the direction HSPCs traveled as they attached to different surfaces in the lab. The researchers tested them on a series of artificial surfaces that were each made entirely of single proteins that the HSPCs latch onto on the walls of blood vessels, as well as on human endothelial cells that more fully replicate the natural environment of the circulatory system.

The researchers also used antibodies to identify the key receptor on the surface of the HSPCs which seems to control this upstream migration.

“Once we block that receptor, greater than 95 percent of the HSPCs cannot swim upstream,” Buffone said.

While these findings are only early results of ongoing research, Hammer’s group believes they are on the right track for determining why HSPCs swim upstream as well as how that behavior can be harnessed to improve bone marrow transplants.

“Why waste so much energy to go against the flow? From an evolutionary sense, there must be an important reason,” Buffone said. “Our current thinking is that once they’ve flown by the place where they can most easily get back into the bone marrow, it’s advantageous to backtrack rather than to continue circulating.”

“Because we have demonstrated this phenomenon both in primary HSPCs and in a cell line, we are poised, through molecular engineering, to identify the mechanisms of upstream migration,” said Hammer. “Eventually, we’d like to reengineer other cells to do the same thing, which will ultimately be useful for treating a wide range of diseases, including inflammation and cancer.”


Explore further:
Transplanted hematopoietic stem cells reverse damage caused by neuro-muscular disorder

More information:
Journal of Cell Science (2017). DOI: 10.1242/jcs.205575

Journal reference:
Journal of Cell Science

Provided by:
University of Pennsylvania

Tagged with:

About author

Related Articles